The Aristotle Classifier: Using the Whole Glycomic Profile To Indicate a Disease State.
暂无分享,去创建一个
David Hua | Heather Desaire | Eden P Go | M. W. Patabandige | E. Go | H. Desaire | Milani Wijeweera Patabandige | Eden P. Go | David C. Hua
[1] William Stafford Noble,et al. Machine learning applications in genetics and genomics , 2015, Nature Reviews Genetics.
[2] E. Go,et al. Label-free quantitation: A new glycoproteomics approach , 2009, Journal of the American Society for Mass Spectrometry.
[3] Lei Xie,et al. Providing data science support for systems pharmacology and its implications to drug discovery , 2016, Expert opinion on drug discovery.
[4] I. Rudan,et al. The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease , 2017, Glycobiology.
[5] Antonio Lavecchia,et al. Machine-learning approaches in drug discovery: methods and applications. , 2015, Drug discovery today.
[6] Dimitrios I. Fotiadis,et al. Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.
[7] P. Rudd,et al. Validation of an automated ultraperformance liquid chromatography IgG N-glycan analytical method applicable to classical galactosaemia , 2018, Annals of clinical biochemistry.
[8] Emily L. Kang,et al. Computational and statistical analysis of metabolomics data , 2015, Metabolomics.
[9] D. Geman,et al. An argument for mechanism-based statistical inference in cancer , 2014, Human Genetics.
[10] Michelle A. Anderson,et al. Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. , 2015, Journal of proteome research.
[11] Bengt Winblad,et al. The role of protein glycosylation in Alzheimer disease , 2014, The FEBS journal.
[12] Xifeng Wu,et al. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer. , 2018, Journal of proteome research.
[13] E. Go,et al. Maximizing coverage of glycosylation heterogeneity in MALDI-MS analysis of glycoproteins with up to 27 glycosylation sites. , 2008, Analytical chemistry.
[14] E. Go,et al. Recombinant Human Lysyl Oxidase-like 2 Secreted from Human Embryonic Kidney Cells Displays Complex and Acidic Glycans at All Three N-Linked Glycosylation Sites. , 2018, Journal of Proteome Research.
[15] Xiaomeng Su,et al. GlycoPep MassList: software to generate massive inclusion lists for glycopeptide analyses , 2016, Analytical and Bioanalytical Chemistry.
[16] J. Kim,et al. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery , 2018, Analytical and Bioanalytical Chemistry.
[17] Bifeng Liu,et al. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS. , 2018, Journal of proteomics.
[18] R. Zubarev,et al. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis , 2017, Arthritis Research & Therapy.